{"status": "ok", "totalResults": 6, "articles": [{"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "Medical Xpress"}, "author": "Science X", "title": "New study shows 1 in 3 men worldwide are infected with genital human papillomavirus - Medical Xpress", "description": "A new study has been published in The Lancet Global Health showing that almost one in three men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and one in five are infected with one or more of what are known as high \u2026", "url": "https://medicalxpress.com/news/2023-09-men-worldwide-infected-genital-human.html", "urlToImage": "https://scx2.b-cdn.net/gfx/news/hires/2023/new-study-shows-1-in-3.jpg", "publishedAt": "2023-09-04T14:16:48Z", "content": "A new study has been published in The Lancet Global Health showing that almost one in three men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and one in f\u2026 [+2890 chars]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "Neurosciencenews.com"}, "author": "Neuroscience News", "title": "Multiple Sclerosis Drug Shows Promise as New Alzheimer\u2019s Therapy - Neuroscience News", "description": "A groundbreaking revealed that ponesimod, a drug originally used to treat multiple sclerosis, shows potential in treating Alzheimer\u2019s disease.", "url": "https://neurosciencenews.com/multiple-sclerosis-drug-alzheimers-23860/", "urlToImage": "https://neurosciencenews.com/files/2023/09/ms-drug-alzheimers-neurosinces.jpg", "publishedAt": "2023-09-03T19:25:18Z", "content": "Summary: A groundbreaking revealed that ponesimod, a drug originally used to treat multiple sclerosis, shows potential in treating Alzheimers disease. Researchers found that the medication reduces ne\u2026 [+6886 chars]"}, {"source": {"id": null, "name": "SciTechDaily"}, "author": null, "title": "Long Haul Ahead: The Prolonged Impact of Severe Long COVID - SciTechDaily", "description": "Charit\u00e9 study tracks patients with pronounced fatigue over 20 months. A new study has found that many people with post-COVID syndrome who suffer from fatigue six months after a coronavirus infection are still severely physically impaired up to 20 months after\u2026", "url": "https://scitechdaily.com/long-haul-ahead-the-prolonged-impact-of-severe-long-covid/", "urlToImage": "https://scitechdaily.com/images/Pain-Fatigue-Cancer-Concept-Art.jpg", "publishedAt": "2023-09-03T18:51:20Z", "content": "ByCharit\u00e9 - Universit\u00e4tsmedizin BerlinSeptember 3, 2023\r\nResearch reveals that individuals with post-COVID syndrome often suffer significant physical impairment up to 20 months after infection. Patie\u2026 [+6711 chars]"}]}